Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Vaccine|September 15, 2004
Differences in the immune response to long term Abeta vaccination in C57BL/6 and B6D2F1 miceTimothy J Seabrook, Melitza Iglesias, Jeanne K Bloom, et al.
Neurobiology of Aging|December 10, 2002
Intranasal immunotherapy for the treatment of Alzheimer's disease: Escherichia coli LT and LT(R192G) as mucosal adjuvantsCynthia A Lemere, Edward T Spooner, Jodi F Leverone, et al.
Neurobiology of Aging|August 18, 2004
Species-specific immune response to immunization with human versus rodent A beta peptideTimothy J Seabrook, Jeanne K Bloom, Melitza Iglesias, et al.
Neurochemical Research|May 10, 2003
Amyloid-beta immunization in Alzheimer's disease transgenic mouse models and wildtype miceCynthia A Lemere, Edward T Spooner, Jodi F Leverone, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 21, 2002
Intraneuronal Abeta42 accumulation in Down syndrome brainChica Mori, Edward T Spooner, Krystyna E Wisniewsk, et al.
Nature Medicine|April 19, 2005
Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivoIgor Klyubin, Dominic M Walsh, Cynthia A Lemere, et al.
The American Journal of Pathology|June 25, 2004
Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervetCynthia A Lemere, Amy Beierschmitt, Melitza Iglesias, et al.
Pageof 2